$0.05 EPS Expected for Kindred Healthcare, Inc. (KND)

October 15, 2017 - By Hazel Jackson

 $0.05 EPS Expected for Kindred Healthcare, Inc. (KND)
Investors sentiment decreased to 1.27 in Q2 2017. Its down 0.18, from 1.45 in 2017Q1. It worsened, as 26 investors sold Kindred Healthcare, Inc. shares while 44 reduced holdings. 28 funds opened positions while 61 raised stakes. 76.03 million shares or 0.40% more from 75.72 million shares in 2017Q1 were reported.
Millennium Mngmt Ltd Liability Com accumulated 0% or 71,177 shares. Susquehanna Intll Gru Llp owns 205,146 shares for 0% of their portfolio. Cibc Asset Mngmt Inc invested in 0% or 10,293 shares. Mutual Of America Limited Co stated it has 165,867 shares. Cubist Systematic Strategies Ltd Llc accumulated 3,435 shares. Renaissance Techs Lc invested in 207,490 shares. Pinebridge Invs Lp accumulated 120,846 shares. Comerica Bank holds 89,735 shares. Walthausen And Ltd Llc holds 2.44% or 2.15 million shares in its portfolio. Hanseatic Mngmt Svcs reported 250 shares. Phoenix Inv Adviser Ltd Liability invested in 1.41% or 179,000 shares. Riverhead Mngmt Ltd Liability Corporation invested in 0% or 6,931 shares. Moreover, Texas Permanent School Fund has 0.01% invested in Kindred Healthcare, Inc. (NYSE:KND) for 62,557 shares. Moreover, Goldman Sachs Group has 0.01% invested in Kindred Healthcare, Inc. (NYSE:KND). Connecticut-based Trexquant Invest Lp has invested 0.12% in Kindred Healthcare, Inc. (NYSE:KND).

Wall Street await Kindred Healthcare, Inc. (NYSE:KND) to release earnings on November, 6. Analysts forecast earnings per share of $0.05, exactly $0.00 or 0.00 % from 2014’s $0.05 EPS. The expected KND’s profit could reach $4.35 million giving the stock 30.00 P/E in the case that $0.05 earnings per share is reported. After posting $0.19 EPS for the previous quarter, Kindred Healthcare, Inc.’s analysts now forecast -73.68 % negative EPS growth. The stock decreased 2.83% or $0.18 on October 13, reaching $6. About 3.78 million shares traded or 188.55% up from the average. Kindred Healthcare, Inc. (NYSE:KND) has declined 11.89% since October 15, 2016 and is downtrending. It has underperformed by 28.59% the S&P500.

Kindred Healthcare, Inc. (NYSE:KND) Ratings Coverage

Among 10 analysts covering Kindred Healthcare Inc. (NYSE:KND), 2 have Buy rating, 2 Sell and 6 Hold. Therefore 20% are positive. Kindred Healthcare Inc. had 28 analyst reports since September 2, 2015 according to SRatingsIntel. The firm has “Hold” rating by RBC Capital Markets given on Wednesday, July 12. The stock of Kindred Healthcare, Inc. (NYSE:KND) earned “Neutral” rating by Mizuho on Thursday, October 1. RBC Capital Markets downgraded Kindred Healthcare, Inc. (NYSE:KND) rating on Thursday, November 10. RBC Capital Markets has “Sector Perform” rating and $9 target. Deutsche Bank maintained it with “Buy” rating and $10 target in Monday, August 7 report. The company was downgraded on Tuesday, November 8 by Stifel Nicolaus. Avondale downgraded the stock to “Mkt Perform” rating in Friday, December 18 report. The firm earned “Outperform” rating on Monday, March 7 by RBC Capital Markets. The firm has “Neutral” rating given on Wednesday, September 16 by JP Morgan. Mizuho maintained Kindred Healthcare, Inc. (NYSE:KND) on Tuesday, November 8 with “Neutral” rating. The firm has “Neutral” rating by Mizuho given on Wednesday, July 6.

Kindred Healthcare, Inc., incorporated on March 27, 1998, is a healthcare services company. The company has market cap of $522.11 million. The Company, through its subsidiaries, operates transitional care hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States. It currently has negative earnings. The Firm operates through divisions: the Kindred at Home division, the hospital division, the Kindred Rehabilitation Services division and the nursing center division.

More notable recent Kindred Healthcare, Inc. (NYSE:KND) news were published by: Fool.com which released: “Here’s Why Kindred Healthcare, Inc. Shares Skyrocketed as Much as 16%” on September 21, 2017, also Seekingalpha.com with their article: “Grab ~9.4% YTM With Kindred Healthcare January 2023 Bonds” published on September 15, 2017, Nasdaq.com published: “Is the Options Market Predicting a Spike in Kindred Healthcare, Inc. (KND) Stock?” on October 04, 2017. More interesting news about Kindred Healthcare, Inc. (NYSE:KND) were released by: Zacks.com and their article: “Is Kindred Healthcare (KND) a Good Stock for Value Investors?” published on September 26, 2017 as well as Fool.com‘s news article titled: “Why Calgon Carbon, Kindred Healthcare, and Impax Laboratories Jumped Today” with publication date: September 21, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com